Abstract
The COVID-19 pandemic has dramatically challenged the national health systems worldwide in the last months. Dalbavancin is a novel antibiotic with a long plasmatic half-life and simplified weekly a...
Funding Information
  • Angelini S.P.A

This publication has 51 references indexed in Scilit: